Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

A Study Comparing Risankizumab to Placebo in Participants With Active Psoriatic Arthritis Including Those Who Have a History of Inadequate Response or Intolerance to Biologic Therapy(Ies) (KEEPsAKE2)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03671148
Recruitment Status : Active, not recruiting
First Posted : September 14, 2018
Last Update Posted : June 11, 2021
Information provided by (Responsible Party):

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Actual Primary Completion Date : June 22, 2020
Estimated Study Completion Date : May 17, 2024
Certification/Extension First Submitted : June 7, 2021